SLSN at a glance
SOLESENCE, INC. (SLSN, SEC CIK 883107) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on August 19, 2026, an 8-K current report on October 5, 2026 and Form 4 insider filings as recently as December 30, 2025. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), SOLESENCE, INC. (SLSN) reported revenue of $62.1 million (up 18.6% from FY2024) and net income of $1.8 million. Diluted EPS was $0.02.
- As of June 30, 2026, 14 institutional investment managers tracked by SignalX reported holding SOLESENCE, INC. (SLSN) shares worth $1.7 million in 13F-HR filings.
- The most recent insider open-market purchase reported on Form 4 was by WHITMORE R JANET on December 24, 2025 of 1,500 shares at $1.91 per share.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $62.1M
- +18.6% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 14 funds
- $1.7M · +0 vs prior quarter
- Latest 8-K
- Aug 21, 2026
- Item 4.02
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Revenue $15,332, down from $20,359 YoY, primarily due to lower product sales
- Cost of revenue 68.8% vs 68.4% YoY, based on $10,548 and $15,332 revenue
- Consumer Products largest category, customer 1 at 58% of revenue; Personal Care Ingredients weakest at 1%
- Cash $1,046 vs $4,108; operating cash flow $1,708 vs $(7,875) YoY
- 2026 capital spending expected at $0.5 million–$1.5 million; inflation and supplier price increases potential headwinds
Risk Factors
- No quarterly risk-factor disclosure; company identifies as a smaller reporting company
- No new regulatory, legal, operational, competitive, market, liquidity, debt, currency, or concentration risks disclosed
AI summary of the SLSN 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 4.02: Non-Reliance on Previously Issued Financial Statements
- Prior financial statements unreliable due to inventory labor and overhead accounting errors under ASC 330
- Affected periods span December 31, 2023 through March 31, 2026, requiring multiple 10-K and 10-Q amendments
AI summaries of SLSN 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for SLSN
Don't miss the next SLSN filing
- Alerts as it files. A push when SLSN files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut SLSN, by share count.
- Ask anything. An AI agent that reads every SLSN filing and answers with sources.
SLSN alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| WHITMORE R JANET | Buy | Dec 24, 2025 | 1,500 | $1.91 |
| WHITMORE R JANET | Buy | Dec 24, 2025 | 1,000 | $1.92 |
| WHITMORE R JANET | Buy | Nov 19, 2025 | 5,000 | $1.95 |
| WHITMORE R JANET | Buy | Nov 19, 2025 | 5,000 | $1.89 |
| WHITMORE R JANET | Buy | Nov 18, 2025 | 267 | $1.83 |
| WHITMORE R JANET | Buy | Nov 17, 2025 | 5,000 | $1.87 |
| WHITMORE R JANET | Buy | Nov 14, 2025 | 19,789 | $1.73 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $52.3M | $62.1M |
| Gross Profit | - | $16.2M | $16.1M |
| Operating Income | - | $5.1M | $1.6M |
| Net Income | - | $4.2M | $1.8M |
| Gross Margin | - | 30.9% | 25.9% |
| Op. Margin | - | 9.8% | 2.5% |
| Net Margin | - | 8.1% | 2.9% |
| Balance Sheet | |||
| Total Assets | $32.9M | $50.0M | $50.1M |
| Equity | $1.9M | $14.9M | $17.6M |
| ROE | - | 28.3% | 10.2% |
| Per Share | |||
| EPS | - | $0.07 | $0.02 |
| Cash Flow | |||
| Operating CF | - | $2.0M | -$8.6M |
| CapEx | $1.1M | $4.6M | - |
Source: XBRL data in SOLESENCE, INC. (SLSN)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate SLSN share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 14 | $1.7M |
| Q1 2026 | 14 | $2.7M |
| Q4 2025 | 14 | $4.6M |
| Q3 2025 | 11 | $8.1M |
| Q2 2025 | 10 | $10.2M |
- BNY Mellon+273.5K (+621%)
- Goldman Sachs Group+65.2K (+236%)
- Vanguard Capital Management LLC+18.8K (+2%)
- Citigroup+4.7K (+478%)
- BlackRock−605.1K (-57%)
- State Street Corp−390.8K (-96%)
- Northern Trust−100.6K (-73%)
- JPMorgan Chase & Co−7.7K (-93%)
- Morgan Stanley−6.0K (-3%)
- Millennium Management+276.5K
- AQR Capital Management+24.7K
Source: 13F-HR filings on SEC EDGAR (aggregated from 63 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
SLSN filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Oct 5, 2026 | - | - | - |
| 8-K | Oct 2, 2026 | - | - | - |
| 8-K | Aug 21, 2026 | - | Analysis | - |
| 8-K | Aug 20, 2026 | - | Analysis | - |
| 10-Q | Aug 19, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Jul 10, 2026 | - | Analysis | - |
| 10-Q | May 12, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | May 12, 2026 | - | Analysis | |
| 8-K | Apr 29, 2026 | - | Analysis | - |
| 8-K | Mar 31, 2026 | - | - | - |
| 10-K | Mar 31, 2026 | Dec 31, 2025 | - | |
| 4 | Dec 30, 2025 | - | - | |
| 4 | Dec 11, 2025 | - | - | |
| 8-K | Dec 3, 2025 | - | - | |
| 8-K | Dec 1, 2025 | - | - | |
| 10-Q | Nov 12, 2025 | Sep 30, 2025 | - | |
| 10-Q | Aug 14, 2025 | Jun 30, 2025 | - | |
| 10-Q | May 13, 2025 | Mar 31, 2025 | - | |
| 10-K | Mar 31, 2025 | Dec 31, 2024 | Analysis | |
| 10-Q | Nov 12, 2024 | Sep 30, 2024 | - | |
| 10-Q | Aug 9, 2024 | Jun 30, 2024 | - | |
| 10-Q | May 13, 2024 | Mar 31, 2024 | - | |
| 10-K | Mar 28, 2024 | Dec 31, 2023 | - | |
| 10-Q | Nov 14, 2023 | Sep 30, 2023 | - | |
| 10-Q | Aug 10, 2023 | Jun 30, 2023 | - |
Related Consumer Staples companies
- CL · Colgate-PalmolivePerfumes, Cosmetics & Other Toilet Preparations
- EPC · EDGEWELL PERSONAL CARE CoPerfumes, Cosmetics & Other Toilet Preparations
- EL · Estée Lauder Companies (The)Perfumes, Cosmetics & Other Toilet Preparations
- IPAR · INTERPARFUMS INCPerfumes, Cosmetics & Other Toilet Preparations
- KVUE · KenvuePerfumes, Cosmetics & Other Toilet Preparations
- OLPX · OLAPLEX HOLDINGS, INC.Perfumes, Cosmetics & Other Toilet Preparations
- WALD · Waldencast plcPerfumes, Cosmetics & Other Toilet Preparations
- ACI · Albertsons Companies IncRetail-Grocery Stores
SLSN SEC filings: frequently asked questions
Which institutions hold SLSN stock?
As of June 30, 2026, the largest SOLESENCE, INC. (SLSN) holders among the 13F filers tracked by SignalX were Vanguard Capital Management LLC ($610,000), BlackRock ($340,000), BNY Mellon ($233,000), Millennium Management ($203,000), Morgan Stanley ($139,000). 13F-HR reports are filed up to 45 days after each quarter ends.
What was SLSN's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), SOLESENCE, INC. (SLSN) reported revenue of $62.1 million (up 18.6% from FY2024) and net income of $1.8 million. Diluted EPS was $0.02. The figures come from the XBRL data in the 10-K.
What did SLSN report in its latest 8-K?
SOLESENCE, INC. (SLSN) filed an 8-K on August 21, 2026 reporting Item 4.02 (Non-Reliance on Previously Issued Financial Statements). Prior financial statements unreliable due to inventory labor and overhead accounting errors under ASC 330.
What are the latest SLSN SEC filings?
SOLESENCE, INC. (SLSN) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on August 19, 2026, an 8-K current report on October 5, 2026 and a Form 4 insider filing on December 30, 2025.
What is SLSN's SEC CIK number?
SOLESENCE, INC. (SLSN)'s SEC Central Index Key (CIK) is 883107. EDGAR lists every SLSN filing under that number.
Ask anything about SLSN
The research agent reads SLSN's filings, financials, insider trades and 13F holders, then answers with sources.